International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2014, 2(4), 126-130
DOI: 10.12691/ijcd-2-4-8
Open AccessArticle

A Retrospective Application of the European Society for Paediatric Gastroenterology Hepatology and Nutrition Guidelines for Diagnosis of Coeliac Disease in New Zealand Children

Wendy Miller1 and Andrew S Day2,

1Paediatric Department, Nelson Hospital, Nelson, New Zealand

2Paediatric Department, Christchurch Hospital, Christchurch, New Zealand

Pub. Date: December 03, 2014

Cite this paper:
Wendy Miller and Andrew S Day. A Retrospective Application of the European Society for Paediatric Gastroenterology Hepatology and Nutrition Guidelines for Diagnosis of Coeliac Disease in New Zealand Children. International Journal of Celiac Disease. 2014; 2(4):126-130. doi: 10.12691/ijcd-2-4-8


In 2012 the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) published an updated guideline for the diagnosis of Coeliac disease, allowing symptomatic individuals with appropriate serology and HLA genotype to be diagnosed without a small bowel biopsy. This retrospective study aimed to assess the applicability of this guideline to children in . Children less than 16 years of age investigated for coeliac disease with small bowel biopsy in between January 2010 and December 2012 were identified. The results of those with tissue transglutaminase IgA (tTG) levels greater than 50 units (10 times upper limit of normal), positive endomysial antibodies and HLA DQ2/DQ8 were used to calculate sensitivity and specificity. Data from 160 children was available: 70 had biopsy-confirmed Coeliac disease, and 90 had negative biopsies. Limited data precluded application of the guidelines to all patients. Using only tTG data, levels above 50 units provided a sensitivity of 67% and a specificity of 92%. Specificity increased to 97% when limited EMA and HLA DQ2/DQ8 data was added. Despite limited data, applying the ESPGHAN guidelines in the paediatric population over this period produced a high specificity (97%). Prospective studies are now required to confirm these findings.

ESPGHAN tissue transglutaminase endomysial antibodies HLA-DQ2/DQ8 children

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Fasano A, Catassi C, “Clincal Practice. Celiac Disease,” N Engl J Med, 367(25), 2419-2426, Dec.2012.
[2]  Husby S, Koletzko S, Korponay-Szabó et al, ”European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease”, JPediatr Gastroenterol Nutr, 54(1), 136-160, Jan.2012.
[3]  Aziz I, Karajeh MA, Zilkha J, Tubman E, Fowles C, Sanders DS, “Change in awareness of gluten-related disorders among chefs and the general public in the UK: a 10-year follow-up study,”Eur J Gastroenterol Hepatol, 26(11), 1228-33, Nov.2014.
[4]  Cook B, Oxner R, Chapman B, et al, “A thirty-year (1970-1999) study of coeliac disease in the Canterbury region of New Zealand,” N Z Med J, 117(1189), Feb.2004.
[5]  Tanpowpong P, Ingham TR, Lampshire PK et al, “Coeliac disease and gluten avoidance in New Zealand children,” Arch Dis Child, 97(1), 12-16, Jan.2012.
[6]  Marsh MN, “Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘coeliac sprue’),” Gastroenterology, 102(1), 330-54, Jan.1992.
[7]  Graphpad Software. QuickCalcs. (accessed January 2014)
[8]  World Health Organisation. WHOanthro v 3.2.2 calculator, January 2011 and macros. (accessed February 2013).
[9]  World Health Organisation. The WHO Child Growth Standards. (accessed February 2013).
[10]  Alessio MG, Tonutti E, Brusca I et al,“Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease,”J Pediatr Gastroenterol Nutr, 55(1), 44-9,Jul.2012.
[11]  Mubarak A, Wolters VM, Gmelig-Meyling FHG et al, “Tissue transglutaminase levels above 100U/mL and celiac disease: A prospective study,” World J Gastroenterol, 18(32), 4399-4403, Aug.2012.
[12]  Sandström O, Rosén A, Largerqvist C, et al, “Transglutaminase IgA antibodies in celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing,” J Pediatr Gastroenterol Nutr, 57(4), 472-6, Oct.2013.
[13]  Klapp G, Masip E, Bolonio M, et al, “Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population,” J Pediatr Gastroenterol Nutr, 56(3), 251-6, March.2013.
[14]  Giersiepen K, Lelgemann M, Stuhldreher N et al, “Accuracy of Diagnostic Antibody Tests for Coeliac Disease in Children: Summary of an Evidence Report,” JPediatr Gastroenterol Nutr, 54(2), 229-241, Feb.2012.
[15]  Piccoli A, Capelli P, Castagnini A et al, “Latent celiac disease in subjects with serum anti-endomysial antibodies and normal intestinal biopsy,” Pediatria Medica e Chirurgica, 24(5), 358-62, Sep-Oct.2002.
[16]  Auricchio R, Tosco A, Piccolo E et al, “Potential celiac children: 9-year follow-up on a gluten-containing diet,” Am J Gastroenterol, 109(6), 913-21, Jun.2014..
[17]  Mariné, M, Farre C, Alsina M et al, “The prevalence of coeliac disease is significantly higher in children compared with adults,” Aliment Pharmacol Therap, 33, 477-486, Feb.2011.
[18]  Westerbeek E, Mouat S, Wesley A, Chin S, “Coeliac disease diagnosed at Starship Children’s Hospital: 1999-2002,” NZ MedJ, 118, 35-43, Aug.2005.
[19]  Christchurch City Council. Age and Ethnicity. (accessed January 2014).
[20]  Gujral N, Freeman HJ, Thomson AB, “Celiac disease: Prevalence, diagnosis, pathogenesis and treatment,” World J Gastroenterol, 18(42), 6036-6059, Nov.2012.
[21]  van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE et al, “Diagnostic Testing for Celiac Disease Among Patients With Abdominal Symptoms A Systematic Review,” JAMA, 303(17), 1738-1746, May.2010.
[22]  Rosen A, Sandstrom O, Olof C et al, “Usefulness of symptoms to screen for coeliac disease,” Pediatrics, 133(2), 211-8, Jan.2014.